The Management of Advanced Testicular Teratoma-Reference-Cited by-同舟云学术

The Management of Advanced Testicular Teratoma

Published:1988-07 Issue:1 Volume:62 Page:63-68
ISSN:0007-1331
Container-title:British Journal of Urology
language:en
Short-container-title:

Author:

PECKHAM M.J.,HORWICH A.,EASTON D. F.,HENDRY W. F.

Publisher

Wiley

Subject

Urology,Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1988.tb04268.x/fullpdf

Reference19 articles.

1. A randomised trial of etoposide (E) & cisplatin (P) & VAB-6 in the treatment (Rx) of “good risk” patients (Pts) with germ cell tumors (GCT). (Abstract);Bosl;Proc. Am. Soc. Clin. Oncol.,1986

2. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors;Bosl;J. Clin. Oncol.,1986

3. Treatment of favorable prognosis non-seminomatous testicular germ-cell tumors with etoposide, cisplatin and reduced dose of Bleomycin;Brada;Cancer. Treat. Rep.,1987

4. Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?;Einhorn;Eur. J. Cancer Clin. Oncol,1986

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of high-dose chemotherapy in relapsed germ cell tumors;World Journal of Urology;2004-04-01

2. Testicular Function in Patients with Testicular Cancer Treated with Bleomycin-Etoposide-Carboplatin (BEC90) Combination Chemotherapy;European Urology;2004-02

3. Current aspects of high-dose chemotherapy in germ-cell tumors;Critical Reviews in Oncology/Hematology;2003-09

4. The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996;BJU International;1999-07

5. Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance;British Journal of Cancer;1998-11